Latest It Compliance News

Richmond Vanadium Technology has appointed Seth McCann as General Manager for Development, Approvals & Studies, positioning the company to advance critical environmental and regulatory milestones for its Queensland vanadium project.

Saunders International has landed a $23 million head contract from the Australian Department of Defence to upgrade fuel infrastructure at RMAF Base Butterworth in Malaysia, reinforcing its Defence sector credentials and expected to boost earnings across FY2027 and FY2028.

New Murchison Gold Limited (ASX:NMG) has amended its JORC reporting for the Cloudkicker deposit while confirming strong, shallow high-grade gold intercepts. Mining at Cloudkicker has begun, expected to add about 20,000 ounces to production over the next 12-18 months.

VRX Silica has raised $4.5 million through strategic equity placements with US-based Nebari Partners and existing shareholder Delphi group, bolstering institutional backing ahead of key project financing milestones for its Arrowsmith North silica sand project.

Keybridge Capital Limited confirms ongoing financial support from WAM Active and outlines plans to meet overdue reporting obligations ahead of a potential ASX delisting.

The Federal Treasurer has barred three foreign shareholders from exercising voting rights in Northern Minerals due to non-compliance with mandated share divestments, intensifying regulatory oversight amid ongoing FIRB investigations.

Group 6 Metals set a new quarterly record processing 77,953 tonnes at its Dolphin Tungsten Mine, producing 21,297 MTUs of tungsten concentrate despite lower feed grades. The company strengthened its cash position to $49.5 million and commenced underground mining, aiming to improve grades and recovery in coming quarters.

West African Resources has hit significant high-grade gold zones below the M5 South underground Ore Reserve at Sanbrado, with drilling results suggesting substantial Ore Reserve growth potential. The company plans to integrate these findings into its 2027 resource update and production outlook.

Paradigm Biopharmaceuticals has secured US$3 million in its latest tranche under a US$27 million convertible note facility, bolstering funding for its global Phase 3 trial of injectable pentosan polysulfate sodium in knee osteoarthritis.

Arafura Rare Earths has secured $361.5 million before costs through a combined placement and share purchase plan, issuing approximately 44.4 million new shares under the SPP and leaving a notable shortfall.

Klevo Rewards has successfully completed a 14-day commercial trial of its stablecoin transaction platform, generating approximately USD 1.22 million in gross revenue and validating its payment capabilities.

CLINUVEL Pharmaceuticals secures Canadian marketing approval for SCENESSE®, expanding access to the only approved systemic photoprotective treatment for erythropoietic protoporphyria (EPP).